PYXS Pyxis Oncology, Inc.
$3.21▼ -1.83%
Healthcare
Other
After hours
$3.15▼ -1.87%
Sep 11, 7:42 PM ET
Volume 1.13M
Avg Volume (10D) 1.19M
Key Metrics & Fundamentals
Market Cap
$267.74M
P/E Ratio
–
Div Yield
–%
52W Range
1.03 - 5.55
% vs 50 MA
6.81%
% vs 200 MA
42.71%
RSI-14
48.8
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.22
Free Cash Flow
-$18.21M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$25.69M
COGS
–
Operating Exp
$25.99M
Operating Income
-$25.99M
EBIT
-$25.99M
Pretax Income
-$25.35M
Net Income
-$25.35M
EPS (Diluted)
-0.40
Price & Volume History
Loading chart…
Recent News
Wedbush Lifts Price Target on Pyxis Oncology to $8 From $6, Keeps Outperform Rating
MT Newswires · Sep 9, 2026 2:13 PM
Pyxis Oncology shares fall 7% despite updated MICVO trial results
InvestorsHub · Sep 9, 2026 2:08 PM
Pyxis Oncology Reports 36% Response Rate in Phase 1 MICVO Study
MT Newswires · Sep 9, 2026 12:26 PM
Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
GlobeNewswire · Sep 9, 2026 11:00 AM
Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
GlobeNewswire · Sep 8, 2026 8:01 PM
Pyxis Oncology Names Thomas Civik CEO, Board Chairman
MT Newswires · Sep 8, 2026 12:41 PM
Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board
GlobeNewswire · Sep 8, 2026 11:30 AM
Pyxis Oncology to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 11:30 AM
Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
GlobeNewswire · Aug 13, 2026 11:00 AM
Wells Fargo Initiates Pyxis Oncology at Overweight With $12 Price Target
MT Newswires · Aug 3, 2026 11:11 AM
Financial Overview - Income Statement
Quarterly
Dec 2025
See PYXS's money flow as a full page
Social Sentiment
No Reddit posts found for PYXS.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.